Search

everythinglearnresearchcommunity

for

Search:↓

EGCG may help treat alopecia areata by blocking certain immune responses and reducing specific harmful immune cells.

Oral JAK inhibitors improved alopecia areata by modulating immune responses and boosting hair growth.

Dithranol reduces inflammation in alopecia areata by lowering certain immune responses.

Anti-IL-12/IL-23 antibody therapy effectively treats psoriasiform skin lesions in IBD patients.

The new skin-targeted COVID-19 vaccine creates strong immune responses and could improve vaccination methods.

Combining hair transplantation with PRP is more effective for treating hair loss than hair transplantation alone.

Atopic dermatitis and alopecia areata share immune and genetic factors, and targeted therapies may help both.

Certain immune cells contribute to severe hair loss in chronic alopecia areata, with Th17 cells possibly having a bigger impact than cytotoxic T cells.

Scalp psoriasis inflammation is mainly caused by bacteria-related triggers.

Alopecia areata involves complex immune dysregulation, mainly driven by Th1 activity, suggesting broader treatment strategies.

Dupilumab successfully treated a woman's alopecia areata and bullous pemphigoid, leading to full hair regrowth and symptom resolution.

Two drugs, ritlecitinib and brepocitinib, improved scalp hair loss condition markers.

Lower CD200R1 on certain immune cells is linked to more severe rheumatoid arthritis and immune imbalance.

The current understanding of frontal fibrosing alopecia involves immune, genetic, hormonal factors, and possibly environmental triggers, but more research is needed for effective treatments.

Dupilumab can both improve and worsen alopecia areata, with higher IgE levels linked to better outcomes.

JAK inhibitors may help treat certain types of hair loss, but more research is needed.

The document concludes that doctors should recognize congenital triangular alopecia to avoid unnecessary treatments, as it does not respond to steroids like alopecia areata does.

Alopecia areata involves complex immune activity, mainly Th1, with potential benefits from broader immune treatments.

Vitiligo and alopecia areata may have similar causes despite their differences.

T-cells in alopecia areata scalp show abnormal regulation, leading to less inflammation.

Atopic dermatitis may trigger alopecia areata, and early treatment can help prevent severe cases.

Flammulina velutipes polysaccharide helps the immune system fight tumors by activating certain pathways.

Alopecia areata is caused by immune system attacks on hair follicles, often triggered by viral infections.

Alopecia areata involves immune activation in the scalp, suggesting treatments targeting TH1, TH2, and IL-23 pathways.

Blocking interferon-gamma might help treat various autoimmune diseases.

Pimecrolimus cream is not effective for treating alopecia areata.

Cholesterol-related compounds can stop hair growth and cause inflammation in a type of scarring hair loss.

Poor response to topical immunotherapy in alopecia areata patients is linked to impaired cell responses.

Frontal fibrosing alopecia shows increased inflammation and JAK-STAT pathway activity without reduced hair proteins.

High levels of the protein Flightless I worsen ulcerative colitis symptoms in mice.